The critical readout is not simply whether a growth appears, but whether the examined growth contains representatives of ectoderm, mesoderm, and endoderm. These three germ-layer derivatives indicate that the tested population can generate diverse differentiated tissues, making the assay a functional test of developmental potential rather than a single-marker identity test.
Histological analysis supplies the evidence needed to interpret a teratoma formation assay. After a growth develops, researchers examine tissue architecture and identify differentiated derivatives associated with the three embryonic germ layers. This tissue-level assessment connects the visible outcome to cellular developmental potential and helps distinguish broad differentiation capacity from the mere presence of an undifferentiated cell population.
Teratoma formation assay results are strongest when interpreted alongside molecular characterization. Molecular tests can support cell identity, whereas the in vivo assay evaluates whether cells demonstrate broad developmental potential through tissue formation. Agreement between these complementary approaches provides a more informative characterization than relying on either molecular evidence or histological findings alone.
The assay introduces candidate pluripotent stem cells into immunodeficient animals and then evaluates any resulting growth through tissue examination. This animal-based design provides an in vivo setting in which the cells' capacity to produce differentiated tissues can be assessed, extending characterization beyond cultured-cell observations or molecular measurements.
A basic workflow begins with candidate pluripotent cells, followed by their introduction into an immunodeficient animal. If a teratoma forms, researchers examine the growth histologically and look for tissue derivatives from ectoderm, mesoderm, and endoderm. The final interpretation depends on the combined observation of the growth and the diversity of tissues identified within it.
It is useful when researchers need functional evidence to support the characterization of cultured cells as pluripotent. The assay can validate cell identity and assess differentiation capacity in regenerative research while complementing molecular tests. Because it is time-consuming and requires careful interpretation, it is best viewed as one component of a broader validation strategy rather than an isolated conclusion.